|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
10/08/2024 |
$903.00 |
$921.97 |
$902.23 |
$913.72 |
2.20M | 10/09/2024 |
$916.29 |
$921.35 |
$912.00 |
$919.74 |
1.82M | 10/10/2024 |
$920.00 |
$922.00 |
$905.15 |
$910.69 |
1.68M | 10/11/2024 |
$916.04 |
$932.24 |
$911.18 |
$932.06 |
2.29M | 10/14/2024 |
$936.00 |
$937.00 |
$926.00 |
$929.51 |
1.55M |
|
Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations. | |
|
Eli Lilly (LLY) has the following price history information. Looking back at LLY historical stock prices for the last five trading days, on October 08, 2024, LLY opened at $903.00, traded as high as $921.97 and as low as $902.23, and closed at $913.72. Trading volume was a total of 2.20M shares. On October 09, 2024, LLY opened at $916.29, traded as high as $921.35 and as low as $912.00, and closed at $919.74. Trading volume was a total of 1.82M shares. On October 10, 2024, LLY opened at $920.00, traded as high as $922.00 and as low as $905.15, and closed at $910.69. Trading volume was a total of 1.68M shares. On October 11, 2024, LLY opened at $916.04, traded as high as $932.24 and as low as $911.18, and closed at $932.06. Trading volume was a total of 2.29M shares. On October 14, 2024, LLY opened at $936.00, traded as high as $937.00 and as low as $926.00, and closed at $929.51. Trading volume was a total of 1.55M shares.
LLY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eli Lilly shares, starting with a $10,000 purchase of LLY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
10/16/2014 |
|
End date: |
10/14/2024 |
|
Start price/share: |
$61.90 |
|
End price/share: |
$929.51 |
|
Starting shares: |
161.55 |
|
Ending shares: |
196.50 |
|
Dividends reinvested/share: |
$30.14 |
|
Total return: |
1,726.53% |
|
Average Annual Total Return: |
33.70% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$182,666.81 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/16/2014 |
|
End date: |
10/14/2024 |
|
Start price/share: |
$61.90 |
|
End price/share: |
$929.51 |
|
Dividends collected/share: |
$30.14 |
|
Total return: |
1,450.33% |
|
Average Annual Total Return: |
31.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$155,086.61 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
10/08/2024 | $913.72 | 10/09/2024 | $919.74 | 10/10/2024 | $910.69 | 10/11/2024 | $932.06 | 10/14/2024 | $929.51 |
|
|